Evidence map›Paper›PMID 24526442›Full record

ArticleInvestigative ophthalmology & visual science2014

Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.

Bongsu Kim, Mohamed H Abdel-Rahman, Tiffany Wang, Severin Pouly, Ashraf M Mahmoud, Colleen M Cebulla

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Investigation of the Possible Protective Effect ofAntioxidants (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).International journal of molecular sciences · 2020
    Review
  8. Review
  9. Effect ofPhysiological genomics · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The role and function of matrix metalloproteinase-8 in rhegmatogenous retinal detachment.International journal of clinical and experimental pathology · 2017
    Article
  19. Non-viral therapeutic approaches to ocular diseases: An overview and future directions.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bongsu KimHavener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Columbus, Ohio, United States.
Mohamed H Abdel-Rahman
Tiffany Wang
Severin Pouly
Ashraf M Mahmoud
Colleen M Cebulla
The Ohio State University · US

Funding

The Ohio State University Center for Clinical and Translational ScienceKL2TR001068 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$2.7M
Genetic polymorphisms in retinal detachment with proliferative vitreoretinopathyK08EY022672 · NEI · OHIO STATE UNIVERSITY · PI CEBULLA, COLLEEN MARIE · 2012 to 2016
$1.1M
The Ohio State University Center for Clinical and Translational Science (KL2)KL2TR000112 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$855k
NCATS NIH HHS KL2 TR000112NCATS NIH HHS KL2 TR001068NCATS NIH HHS KL2TR001068NEI NIH HHS K08 EY022672NEI NIH HHS K08EY022672
6 · The paper itself

Abstract

purposeMatrix metalloproteinases (MMPs) and their inhibitors play a role in the pathobiology of retinal detachment (RD) and proliferative vitreoretinopathy (PVR). Proliferative vitreoretinopathy is facilitated by chronic retinal detachment and involves excessive deposition of extracellular matrix (ECM) proteins. Matrix metalloproteinase-2 and -13 are important modulators of the ECM which have not been evaluated in RD. The purpose of this study was to investigate the retinal expression of select MMPs, including MMP-12, MMP-13, and associated inhibitors in a murine model of retinal detachment.

methodsTransient or chronic retinal detachments (RDs) were induced by subretinal injection of either saline (SA) or hyaluronic acid (HA) in C57BL/6 mice. To confirm that the HA-RD model has features consistent with PVR-like changes, glial activation and subretinal fibrosis were evaluated with immunofluorescence, dilated fundus examination, and spectral-domain optical coherence tomography (SD-OCT). Gene expression was quantified by qRT-PCR. Proteins were assayed by immunoblot and immunohistochemistry.

resultsHyaluronic acid RD eyes developed gliosis and subretinal fibrosis on dilated exam, SD-OCT, and immunofluorescence analysis. Gene expression of Mmp-12 and Mmp-13, and Timp-1 was strongly upregulated at all time points in RD compared with controls. Timp-2, Mmp-2, and Mmp-9 expression was modest. Hyaluronic acid RDs exhibited more MMP and TIMP expression than SA-RDs. MMP-12, -13, and TIMP-1 proteins were elevated in RDs compared with controls. Immunohistochemistry revealed moderate to strong MMP-13 levels in subretinal space macrophages.

conclusionsFibrosis can develop in the HA-RD model. There is an upregulation of select MMPs that may modulate the wound healing process following RD.

Indexed as

Gene Expression RegulationAnimalsBlotting, WesternDisease Models, AnimalImmunohistochemistryMatrix Metalloproteinase 12Matrix Metalloproteinase 13MiceMice, Inbred C57BLMicroscopy, FluorescenceReal-Time Polymerase Chain ReactionRetinaRetinal DetachmentRNATissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-2Matrix Metalloproteinase 12Matrix Metalloproteinase 13RNATissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-2extracellular matrixmatrix metalloproteinaseMMP-12MMP-13proliferative vitreoretinopathyretinal detachmentspectral-domain optical coherence tomographyTIMP-1TIMP-2tissue inhibitor metalloproteinase

Identifiers

PMID24526442
PMCPMC3979233
OpenAlexW2069264071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.